GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 632 filers reported holding GLAXOSMITHKLINE PLC in Q3 2013. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $741,000 | +35.5% | 17,585 | +23.6% | 0.46% | +12.4% |
| Q4 2016 | $547,000 | -27.1% | 14,230 | -18.3% | 0.41% | -25.4% |
| Q3 2016 | $750,000 | +49.7% | 17,410 | +50.4% | 0.55% | +37.8% |
| Q2 2016 | $501,000 | -24.7% | 11,575 | -33.1% | 0.40% | -21.3% |
| Q3 2015 | $665,000 | -10.3% | 17,305 | -2.8% | 0.51% | -8.1% |
| Q2 2015 | $741,000 | -12.1% | 17,807 | -0.2% | 0.55% | -6.9% |
| Q1 2015 | $843,000 | +10.6% | 17,847 | +0.0% | 0.59% | +20.5% |
| Q4 2014 | $762,000 | -8.5% | 17,842 | -1.6% | 0.49% | -6.1% |
| Q3 2014 | $833,000 | -11.2% | 18,125 | +3.3% | 0.52% | -12.2% |
| Q2 2014 | $938,000 | +0.3% | 17,543 | +0.3% | 0.60% | -8.0% |
| Q1 2014 | $935,000 | +13.1% | 17,492 | +12.9% | 0.65% | +32.1% |
| Q4 2013 | $827,000 | -17.1% | 15,495 | -22.0% | 0.49% | -28.5% |
| Q3 2013 | $997,000 | +3.6% | 19,865 | +3.2% | 0.69% | +4.2% |
| Q2 2013 | $962,000 | – | 19,255 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |